share_log

Assessing TransMedics Gr: Insights From 6 Financial Analysts

Assessing TransMedics Gr: Insights From 6 Financial Analysts

评估 transmedics Gr:来自6位财务分析师的见解
Benzinga ·  08/01 09:00
Across the recent three months, 6 analysts have shared their insights on TransMedics Gr (NASDAQ:TMDX), expressing a variety of opinions spanning from bullish to bearish.
在最近的三个月中,有6位分析师分享了他们对TransMedics Gr (NASDAQ:TMDX)的观点,表达了从看好到看淡的各种意见。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格总结了分析师们最近的评级,揭示了过去30天内情绪的变化并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $160.17, a high estimate of $200.00, and a low estimate of $120.00. Marking an increase of 33.7%, the current average surpasses the previous average price target of $119.80.
分析师12个月的目标价预测揭示了平均目标价为160.17美元,最高预估为200.00美元,最低预估为120.00美元的各种预测。当前的平均目标价比之前的平均目标价119.80美元增长了33.7%。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查:一项详尽的研究
The analysis of recent analyst actions sheds light on...
最近分析师行动分析...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发